This is an observational, cohort-based, single-site, prospective study conducted in accordance with ISO 14155-1:2003 and ISO 14155-1:2011. The primary objectives are to evaluate the accuracy of the device's measurements/readings in comparison to a gold standard or standard of care patient monitor.
This is an observational, cohort-based, single-site, prospective clinical study enrolling up to 100 patients who are hospitalized in the internal ward. There is no control group. The primary objectives of the study are: 1. Evaluate the body temperature measured by the ear unit and validate its accuracy. 2. Evaluate the accuracy of SPO2 signals and results by comparing the readings to a gold standard device with a finger sensor. 3. Evaluate the ECG and respiration signals recorded by the patch device by comparing them to the signals recorded by a patient monitor with standard leads. The secondary objectives of the study are: 4. Usability - evaluate the ease of use of the device by medical staff and patients (e.g., positioning, activation, replacement of patch, understanding processes and requirements). 5. Evaluate the signals quality and the patch adherence after 5 - 7 days on the chest. The study will assess the safety and effectiveness of the Vital Signs Monitoring System (VSMS) for its intended use/proposed indications. Data will be collected while the VSMS is adhered to each patient for the entire hospitalization period, up to 7 days. There is no follow-up required.
Study Type
OBSERVATIONAL
Enrollment
100
The VSMS will be adhered to each enrolled patient for the entire hospitalization period.
Internal Ward B, Aliza Begin Building, Assaf Harofe Hospital (2nd Floor)
P.O. Beer Ya'akov, Zerifin, Israel
RECRUITINGSkin Temperature measured in units of Celsius/Fahrenheit
Validation of measurement accuracy of skin temperature as compared to gold standard.
Time frame: 6-10 days
Oxygen Saturation measured in units of percentage peripheral saturated oxygen
Validation of measurement accuracy of peripheral oxygen saturation as compared to gold standard.
Time frame: 6-10 days
.ECG signal recording and Respiration measured in units heart beat per minute
Assess quality of device's recorded ECG and respiration signals as compared to patient monitor with standard leads
Time frame: 6-10 days
Quality of recorded signal
Evaluate the quality of recorded signals in time by comparing signal of day 1 with signal in last day of adherence of the patch
Time frame: after 5-7 days of device usage
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.